nach oben

Supportive Care in Cancer

Erschienen in:

03.06.2019 | Letter to the Editor

Comments on: High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany

verfasst von: Amélie Cransac, Serge Aho, Mathieu Boulin

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

We read with interest the work of Feiten et al. entitled “High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany” [1]. The authors performed an estimation of adherence in multiple myeloma patients treated by IMIDS in seven group practices in Germany. They used three different methods: a questionnaire with an estimation of patients’ adherence by the patient, by the oncologist, and a calculation with the retrospective analysis of prescriptions. …

Feiten S, Chakupurakal G, Feustel HP, Maasberg M, Otremba B, Ehscheidt P, Hensel M, Hansen R, Weide R (2019) High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany. Support Care Cancer. https://doi.org/10.1007/s00520-019-04721-4 CrossRef

Mateos MV, Ocio EM, Paiva B, Rosinol L, Martinez-Lopez J, Blade J, Lahuerta JJ, Garcia-Sanz R, San Miguel JF (2015) Treatment for patients with newly diagnosed multiple myeloma in 2015. Blood Rev 29(6):387–403. https://doi.org/10.1016/j.blre.2015.06.001 CrossRefPubMed

Lee C, Grigorian M, Nolan R, Binder G, Rice G (2016) A retrospective study of direct cost to patients associated with the use of oral oncology medications for the treatment of multiple myeloma. J Med Econ 19(4):397–402. https://doi.org/10.3111/13696998.2015.1130710 CrossRefPubMed

Cransac A, Aho S, Chretien ML, Giroud M, Caillot D, Boulin M (2019) Adherence to immunomodulatory drugs in patients with multiple myeloma. PLoS One 14(3):e0214446. https://doi.org/10.1371/journal.pone.0214446 CrossRefPubMedPubMedCentral

Huang WC, Chen CY, Lin SJ, Chang CS (2016) Medication adherence to oral anticancer drugs: systematic review. Expert Rev Anticancer Ther 16(4):423–432. https://doi.org/10.1586/14737140.2016.1159515 CrossRefPubMed

Bartolucci F (2015) Statistical analysis of questionnaires: a unified approach based on R and Stata. Chapman and Hall/CRC

Carpenter JR, Kenward MG (2013) Multiple imputation and its application, 1st edn. John Wiley & Sons, Chichester, West SussexCrossRef

Dogan NO (2018) Bland-Altman analysis: a paradigm to understand correlation and agreement. Turk J Emerg Med 18(4):139–141. https://doi.org/10.1016/j.tjem.2018.09.001 CrossRefPubMedPubMedCentral

Titel: Comments on: High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany
verfasst von: Amélie Cransac
Serge Aho
Mathieu Boulin
Publikationsdatum: 03.06.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 1/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-019-04886-y

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Comments on: High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial

Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients

Nutritional parameters associated with hospital admissions in patients being treated for head and neck cancer

Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer

The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab

Emotion And Symptom-focused Engagement (EASE): a randomized phase II trial of an integrated psychological and palliative care intervention for patients with acute leukemia

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie